SANDOZ AZITHROMYCIN DIN 02332388
Status: Marketed
Holder: SANDOZ CANADA INCORPORATED
Molecule: AZITHROMYCIN (AZITHROMYCIN DIHYDRATE)
Available to quote
Health Canada record
| Active ingredient(s) | AZITHROMYCIN (AZITHROMYCIN DIHYDRATE) 100 MG |
|---|---|
| Dosage form | Powder For Suspension |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | J01FA10 AZITHROMYCIN |
| Original market date | 08-Sep-2009 |
| Current status date | 27-Oct-2021 |
| Source | Health Canada DPD |
Establishment licence of the holder
Sandoz Canada Incorporated — licence 101370, currently licensed, last inspection rating C (2025-02-25).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing AZITHROMYCIN (AZITHROMYCIN DIHYDRATE)
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02480700 | AG-AZITHROMYCIN | ANGITA PHARMA INC. | Tablet | AZITHROMYCIN (AZITHROMYCIN DIHYDRATE) 250 MG | Marketed |
| 02477610 | ALTA-AZITHROMYCIN | ALTAMED PHARMA | Tablet | AZITHROMYCIN (AZITHROMYCIN DIHYDRATE) 250 MG | Approved |
| 02415542 | APO-AZITHROMYCIN Z | APOTEX INC | Tablet | AZITHROMYCIN (AZITHROMYCIN DIHYDRATE) 250 MG | Marketed |
| 02482371 | AURO-AZITHROMYCIN | AURO PHARMA INC | Powder For Suspension | AZITHROMYCIN (AZITHROMYCIN DIHYDRATE) 200 MG | Marketed |
| 02482363 | AURO-AZITHROMYCIN | AURO PHARMA INC | Powder For Suspension | AZITHROMYCIN (AZITHROMYCIN DIHYDRATE) 100 MG | Marketed |
| 02545969 | AZITHROMYCIN | 10445517 CANADA INC / NORTH PHARMACEUTICALS / DAC PHARMACEUTICALS | Tablet | AZITHROMYCIN (AZITHROMYCIN DIHYDRATE) 250 MG | Marketed |
| 02330881 | AZITHROMYCIN | SANIS HEALTH INC | Tablet | AZITHROMYCIN (AZITHROMYCIN DIHYDRATE) 250 MG | Marketed |
| 02545977 | AZITHROMYCIN | 10445517 CANADA INC / NORTH PHARMACEUTICALS / DAC PHARMACEUTICALS | Tablet | AZITHROMYCIN (AZITHROMYCIN DIHYDRATE) 600 MG | Approved |
| 02442434 | AZITHROMYCIN | SIVEM PHARMACEUTICALS ULC | Tablet | AZITHROMYCIN (AZITHROMYCIN DIHYDRATE) 250 MG | Marketed |
| 02523825 | AZITHROMYCIN FOR INJECTION | JAMP PHARMA CORPORATION | Powder For Solution | AZITHROMYCIN (AZITHROMYCIN DIHYDRATE) 500 MG | Marketed |
| 02524449 | AZITHROMYCIN FOR INJECTION | GENERIC MEDICAL PARTNERS INC | Powder For Solution | AZITHROMYCIN (AZITHROMYCIN DIHYDRATE) 500 MG | Marketed |
| 02483890 | AZITHROMYCIN FOR INJECTION USP | STERIMAX INC | Powder For Solution | AZITHROMYCIN (AZITHROMYCIN DIHYDRATE) 500 MG | Marketed |
| 02567881 | BIO-AZITHROMYCIN | BIOMED PHARMA | Tablet | AZITHROMYCIN (AZITHROMYCIN DIHYDRATE) 250 MG | Approved |
| 02567903 | BIO-AZITHROMYCIN | BIOMED PHARMA | Tablet | AZITHROMYCIN (AZITHROMYCIN DIHYDRATE) 600 MG | Approved |
| 02446359 | IPG-AZITHROMYCIN | MARCAN PHARMACEUTICALS INC | Tablet | AZITHROMYCIN (AZITHROMYCIN DIHYDRATE) 250 MG | Approved |
| 02446367 | IPG-AZITHROMYCIN | MARCAN PHARMACEUTICALS INC | Tablet | AZITHROMYCIN (AZITHROMYCIN DIHYDRATE) 600 MG | Approved |
| 02452316 | JAMP-AZITHROMYCIN | JAMP PHARMA CORPORATION | Tablet | AZITHROMYCIN (AZITHROMYCIN DIHYDRATE) 600 MG | Approved |
| 02452308 | JAMP-AZITHROMYCIN | JAMP PHARMA CORPORATION | Tablet | AZITHROMYCIN (AZITHROMYCIN DIHYDRATE) 250 MG | Marketed |
| 02502038 | M-AZITHROMYCIN | MANTRA PHARMA INC | Tablet | AZITHROMYCIN (AZITHROMYCIN DIHYDRATE) 250 MG | Marketed |
| 02502046 | M-AZITHROMYCIN | MANTRA PHARMA INC | Tablet | AZITHROMYCIN (AZITHROMYCIN DIHYDRATE) 600 MG | Approved |
| 02452332 | MAR-AZITHROMYCIN | MARCAN PHARMACEUTICALS INC | Tablet | AZITHROMYCIN (AZITHROMYCIN DIHYDRATE) 600 MG | Approved |
| 02452324 | MAR-AZITHROMYCIN | MARCAN PHARMACEUTICALS INC | Tablet | AZITHROMYCIN (AZITHROMYCIN DIHYDRATE) 250 MG | Marketed |
| 02479680 | NRA-AZITHROMYCIN | NORA PHARMA INC | Tablet | AZITHROMYCIN (AZITHROMYCIN DIHYDRATE) 250 MG | Marketed |
| 02479699 | NRA-AZITHROMYCIN | NORA PHARMA INC | Tablet | AZITHROMYCIN (AZITHROMYCIN DIHYDRATE) 600 MG | Approved |
| 02562944 | PRO-AZITHROMYCINE | PRO DOC LIMITEE | Tablet | AZITHROMYCIN (AZITHROMYCIN DIHYDRATE) 600 MG | Approved |
| 02310600 | PRO-AZITHROMYCINE | PRO DOC LIMITEE | Tablet | AZITHROMYCIN (AZITHROMYCIN DIHYDRATE) 250 MG | Marketed |
| 02548895 | RIVA-AZITHROMYCIN | LABORATOIRE RIVA INC. | Tablet | AZITHROMYCIN (AZITHROMYCIN DIHYDRATE) 600 MG | Approved |
| 02275309 | RIVA-AZITHROMYCIN | LABORATOIRE RIVA INC. | Tablet | AZITHROMYCIN (AZITHROMYCIN DIHYDRATE) 250 MG | Marketed |
| 02332396 | SANDOZ AZITHROMYCIN | SANDOZ CANADA INCORPORATED | Powder For Suspension | AZITHROMYCIN (AZITHROMYCIN DIHYDRATE) 200 MG | Marketed |
| 02265826 | SANDOZ AZITHROMYCIN | SANDOZ CANADA INCORPORATED | Tablet | AZITHROMYCIN (AZITHROMYCIN DIHYDRATE) 250 MG | Marketed |
| 02480719 | AG-AZITHROMYCIN | ANGITA PHARMA INC. | Tablet | AZITHROMYCIN (AZITHROMYCIN DIHYDRATE) 600 MG | Dormant |
| 02477629 | AZITHROMYCIN | ALTAMED PHARMA | Tablet | AZITHROMYCIN (AZITHROMYCIN DIHYDRATE) 600 MG | Cancelled Pre Market |
| 02354802 | ZMAX SR | PFIZER CANADA ULC | Granules For Suspension (Extended-Releas | AZITHROMYCIN (AZITHROMYCIN DIHYDRATE) 2 G | Cancelled Post Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 10575 | 2009-09-08 | Abbreviated New Drug Submission (ANDS) |